{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T08:28:59.544744+00:00","published_at":"2026-10-17T04:46:47.349247+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:axhw0idbf4t4","event_type":"CFO_CHANGED","effective_at":"2026-04-28","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:michael-tung","alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7"],"caused_claim_ids":["alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:91f8e4352a443beacde67ed1280e0d88aee46f3a73d11414ab14ab4825445006"],"summary":"Michael Tung executive of vTv Therapeutics Inc., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1063w6613d6y0o","event_type":"CEO_CHANGED","effective_at":"2026-04-28","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:paul-sekhri","alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7"],"caused_claim_ids":["alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:de042f47f2ca11c9ac424d29578ac4f11fcaa8f24a3485d7efb0d4d56a5c5fba"],"summary":"Paul Sekhri executive of vTv Therapeutics Inc., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1i604dy1rsyqgc","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:anne-m-phillips","alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7"],"caused_claim_ids":["alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60"],"summary":"Anne M. Phillips seat on vTv Therapeutics Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1jmq04jab3af5","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:raymond-cheong","alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7"],"caused_claim_ids":["alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60"],"summary":"Raymond Cheong seat on vTv Therapeutics Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:mcvrku105qifc","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:srinivas-akkaraju-m-d-ph-d","alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7"],"caused_claim_ids":["alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60"],"summary":"Srinivas Akkaraju, M.D., Ph.D. seat on vTv Therapeutics Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1s5soj01sn32c8","event_type":"COMMITTEE_CREATED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:committee:vtv-therapeutics-inc:audit-compensation-chair","alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7"],"caused_claim_ids":["alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60"],"summary":"Audit; Compensation · Chair committee of vTv Therapeutics Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:zdms8vctrv8p","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:anne-m-phillips","alpha:committee:vtv-therapeutics-inc:audit-compensation-chair"],"caused_claim_ids":["alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60"],"summary":"Anne M. Phillips member of Audit; Compensation · Chair, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1et2um91l4jrtx","event_type":"COMMITTEE_CREATED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:committee:vtv-therapeutics-inc:compensation-nominating-and-governance-chair","alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7"],"caused_claim_ids":["alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60"],"summary":"Compensation; Nominating and Governance · Chair committee of vTv Therapeutics Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:9iq3ue6lek4e","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:raymond-cheong","alpha:committee:vtv-therapeutics-inc:compensation-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60"],"summary":"Raymond Cheong member of Compensation; Nominating and Governance · Chair, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:15uw9w7cjhhnd","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:fahed-al-marzooqi","alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7"],"caused_claim_ids":["alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60"],"summary":"Fahed Al Marzooqi seat on vTv Therapeutics Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1j1ka4c1im2rzo","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:paul-sekhri","alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7"],"caused_claim_ids":["alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60"],"summary":"Paul Sekhri seat on vTv Therapeutics Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:p9w4427sfpyg","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2022-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:fahed-al-marzooqi","alpha:committee:vtv-therapeutics-inc:compensation"],"caused_claim_ids":["alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_record:16"],"evidence_ids":["alpha:projection-evidence:26d6d939efc5cbc260a4f18466e0a23492ee99e21a5c37da9713c6d743fc675b"],"summary":"Fahed Al Marzooqi member of Compensation, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ok3b2k1md0hx4","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:richard-s-nelson","alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7"],"caused_claim_ids":["alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60"],"summary":"Richard S. Nelson seat on vTv Therapeutics Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:5","subject_id":"alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:anne-m-phillips","object_label":"Anne M. Phillips","object_source_name_forms":[],"value":"Anne M. Phillips: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:anne-m-phillips","name":"Anne M. Phillips"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"vTv Therapeutics Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641489/000164148925000024/vtvt-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.376+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:6","subject_id":"alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:fahed-al-marzooqi","object_label":"Fahed Al Marzooqi","object_source_name_forms":[],"value":"Fahed Al Marzooqi: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:fahed-al-marzooqi","name":"Fahed Al Marzooqi"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"vTv Therapeutics Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641489/000164148925000024/vtvt-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.376+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:7","subject_id":"alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:paul-sekhri","object_label":"Paul Sekhri","object_source_name_forms":[],"value":"Paul Sekhri: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:paul-sekhri","name":"Paul Sekhri"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"vTv Therapeutics Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641489/000164148925000024/vtvt-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.376+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:8","subject_id":"alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:raymond-cheong","object_label":"Raymond Cheong","object_source_name_forms":[],"value":"Raymond Cheong: Director, Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:raymond-cheong","name":"Raymond Cheong"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"vTv Therapeutics Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641489/000164148925000024/vtvt-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.376+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:9","subject_id":"alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-s-nelson","object_label":"Richard S. Nelson","object_source_name_forms":[],"value":"Richard S. Nelson: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-s-nelson","name":"Richard S. Nelson"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"vTv Therapeutics Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641489/000164148925000024/vtvt-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.376+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:10","subject_id":"alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:srinivas-akkaraju-m-d-ph-d","object_label":"Srinivas Akkaraju, M.D., Ph.D.","object_source_name_forms":[],"value":"Srinivas Akkaraju, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:srinivas-akkaraju-m-d-ph-d","name":"Srinivas Akkaraju, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"vTv Therapeutics Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641489/000164148925000024/vtvt-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.376+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:11","subject_id":"alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:michael-tung","object_label":"Michael Tung","object_source_name_forms":[],"value":"Michael Tung: Executive Vice President and Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:michael-tung","name":"Michael Tung"},"title":"Executive Vice President and Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:91f8e4352a443beacde67ed1280e0d88aee46f3a73d11414ab14ab4825445006","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VTVT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641489/000164148926000015/vtvt-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T10:01:16.280864+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:12","subject_id":"alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:paul-sekhri","object_label":"Paul Sekhri","object_source_name_forms":[],"value":"Paul Sekhri: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:paul-sekhri","name":"Paul Sekhri"},"title":"President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:de042f47f2ca11c9ac424d29578ac4f11fcaa8f24a3485d7efb0d4d56a5c5fba","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VTVT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641489/000164148926000015/vtvt-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T10:01:15.773812+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_record:16","subject_id":"alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Anne M. Phillips; Members Anne M. Phillips (Chair); Fahed Al Marzooqi; Raymond Cheong","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Anne M. Phillips","members":[{"display_name":"Anne M. Phillips","person_slug":"anne-m-phillips","is_chair":true},{"display_name":"Fahed Al Marzooqi","person_slug":"fahed-al-marzooqi","is_chair":false},{"display_name":"Raymond Cheong","person_slug":"raymond-cheong","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:26d6d939efc5cbc260a4f18466e0a23492ee99e21a5c37da9713c6d743fc675b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1641489/000164148925000024/vtvt-20250425.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"vTv Therapeutics Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641489/000164148925000024/vtvt-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.376+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:91f8e4352a443beacde67ed1280e0d88aee46f3a73d11414ab14ab4825445006","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VTVT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641489/000164148926000015/vtvt-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T10:01:16.280864+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:de042f47f2ca11c9ac424d29578ac4f11fcaa8f24a3485d7efb0d4d56a5c5fba","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VTVT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641489/000164148926000015/vtvt-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T10:01:15.773812+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:26d6d939efc5cbc260a4f18466e0a23492ee99e21a5c37da9713c6d743fc675b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1641489/000164148925000024/vtvt-20250425.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.834,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.882,"cross_source_agreement":0.75,"temporal_completeness":0.533},"diagnostics":{"published_claims":22,"factual_claims":22,"claims_with_linked_evidence":22,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":15,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:47.349247+00:00","observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":"2026-10-17T04:46:47.349247+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":22,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/vtv-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}